These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16162697)

  • 1. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.
    Littner MR; Leung FW; Ballard ED; Huang B; Samra NK;
    Chest; 2005 Sep; 128(3):1128-35. PubMed ID: 16162697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.
    ; Holbrook JT; Wise RA; Gold BD; Blake K; Brown ED; Castro M; Dozor AJ; Lima JJ; Mastronarde JG; Sockrider MM; Teague WG
    JAMA; 2012 Jan; 307(4):373-81. PubMed ID: 22274684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease.
    Shimizu Y; Dobashi K; Kobayashi S; Ohki I; Tokushima M; Kusano M; Kawamura O; Shimoyama Y; Utsugi M; Sunaga N; Ishizuka T; Mori M
    Tohoku J Exp Med; 2006 Jul; 209(3):181-9. PubMed ID: 16778364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux.
    Sharma B; Sharma M; Daga MK; Sachdev GK; Bondi E
    World J Gastroenterol; 2007 Mar; 13(11):1706-10. PubMed ID: 17461474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications.
    Sandur V; Murugesh M; Banait V; Rathi PM; Bhatia SJ; Joshi JM; Kate A
    J Postgrad Med; 2014; 60(3):282-6. PubMed ID: 25121368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy.
    Wong CH; Chua CJ; Liam CK; Goh KL
    Aliment Pharmacol Ther; 2006 May; 23(9):1321-7. PubMed ID: 16629937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.
    Levin TR; Sperling RM; McQuaid KR
    Am J Gastroenterol; 1998 Jul; 93(7):1060-3. PubMed ID: 9672330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
    Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
    Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled lidocaine for the treatment of asthma: lack of efficacy in two double-blind, randomized, placebo-controlled clinical studies.
    Abuan T; Yeager M; Montgomery AB
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):381-8. PubMed ID: 20958143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of esomeprazole for treatment of poorly controlled asthma.
    ; Mastronarde JG; Anthonisen NR; Castro M; Holbrook JT; Leone FT; Teague WG; Wise RA
    N Engl J Med; 2009 Apr; 360(15):1487-99. PubMed ID: 19357404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.
    Kiljander TO; Junghard O; Beckman O; Lind T
    Am J Respir Crit Care Med; 2010 May; 181(10):1042-8. PubMed ID: 20110554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
    Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
    Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.